Insider Trading History of Lewis Earl

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lewis Earl since 2015. This trader's CIK number is 1230427. At the time of last reporting, Lewis Earl was the Director of Tecogen Inc.. (stock ticker symbol TGEN). Also see all insider trading activities at Tecogen Inc..

Note that in the past Lewis Earl also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Tecogen Inc. (TGEN) by Lewis Earl

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 TGEN 10,000 $27,005 0 $0 0 $0
2024 TGEN 156,152 $110,688 0 $0 0 $0
2023 TGEN 113,500 $110,579 0 $0 0 $0
2022 TGEN 13,183 $12,623 0 $0 0 $0
2021 TGEN 15,000 $28,200 0 $0 0 $0
2020 TGEN 11,711 $9,603 0 $0 0 $0

Yearly summary of insider trading at Harvard Bioscience Inc (HBIO) by Lewis Earl

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 HBIO 22,238 $52,620 0 $0 0 $0
2016 HBIO 27,221 $89,284 23,088 $55,872 0 $0
2015 HBIO 0 $0 0 $0 57,785 $224,065

Yearly summary of insider trading at Flir Systems Inc (FLIR) by Lewis Earl

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 FLIR 0 $0 0 $0 527,530 $15,447,999
2020 FLIR 0 $0 30,000 $1,077,900 0 $0
2019 FLIR 0 $0 288,801 $14,995,523 232,100 $7,025,667
2018 FLIR 0 $0 84,508 $5,080,297 189,800 $4,866,472
2017 FLIR 0 $0 183,218 $8,220,525 379,500 $9,630,645
2016 FLIR 0 $0 154,963 $4,874,189 0 $0
2015 FLIR 0 $0 324,530 $10,032,546 274,492 $3,450,363

Yearly summary of insider trading at Nxstage Medical, Inc. (NXTM) by Lewis Earl

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 NXTM 21,000 $304,017 18,020 $356,075 47,468 $738,125
2015 NXTM 0 $0 0 $0 14,000 $194,320


Insider trading activities at 4 companies by Lewis Earl:

1. Tecogen Inc. (TGEN)

2. Harvard Bioscience Inc (HBIO)

3. Flir Systems Inc (FLIR)

4. Nxstage Medical, Inc. (NXTM)

Table 1. Insider trading of Tecogen Inc. (TGEN) by Lewis Earl

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-03-27 TGEN Buy 5,000 2.52 12,595
2026-03-26 TGEN Buy 5,000 2.88 14,410
2024-11-22 TGEN Buy 100,000 .71 71,000
2023-10-09 TGEN Buy 2,000 .80 1,600
2024-07-15 TGEN Buy 10,000 .68 6,800
2024-07-15 TGEN Buy 10,000 .68 6,800
2024-05-01 TGEN Buy 5,000 .75 3,750
2024-04-24 TGEN Buy 10,000 .68 6,800
2024-01-24 TGEN Buy 9,152 .78 7,138
2024-01-23 TGEN Buy 10,000 .68 6,800
2023-10-18 TGEN Buy 25,000 .91 22,750
2023-10-09 TGEN Buy 2,000 .80 1,600
2023-09-08 TGEN Buy 10,000 .95 9,500
2023-09-05 TGEN Buy 10,000 1.00 10,000
2023-08-14 TGEN Buy 1,500 1.00 1,500
2023-05-15 TGEN Buy 10,000 .96 9,600
2023-03-24 TGEN Buy 8,194 .93 7,579
2023-03-27 TGEN Buy 806 .98 793
2023-03-28 TGEN Buy 6,000 1.02 6,132
2023-03-29 TGEN Buy 20,000 1.18 23,500
2023-03-22 TGEN Buy 5,000 .87 4,350
2023-03-20 TGEN Buy 15,000 .89 13,275
2022-09-29 TGEN Buy 5,000 .97 4,850
2022-09-28 TGEN Buy 8,183 .95 7,773
2021-08-17 TGEN Buy 15,000 1.88 28,200
2020-06-08 TGEN Buy 11,711 .82 9,603

Table 2. Insider trading of Harvard Bioscience Inc (HBIO) by Lewis Earl

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-05-25 HBIO Buy 12,238 2.35 28,820
2017-05-24 HBIO Buy 5,000 2.37 11,850
2017-05-23 HBIO Buy 5,000 2.39 11,950
2016-12-06 HBIO Sale 23,088 2.42 55,872
2015-12-02 HBIO Buy 27,221 3.28 89,284
2015-06-09 HBIO Option Ex 10,371 3.13 32,513
2015-03-04 HBIO Option Ex 47,414 4.04 191,552

Table 3. Insider trading of Flir Systems Inc (FLIR) by Lewis Earl

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-04-28 FLIR Option Ex 272,406 31.36 8,542,652
2021-03-31 FLIR Option Ex 161,000 22.30 3,590,300
2021-01-13 FLIR Option Ex 94,124 35.22 3,315,047
2020-11-04 FLIR Sale 30,000 35.93 1,077,900
2019-11-05 FLIR Sale 23,585 53.57 1,263,448
2019-04-29 FLIR Sale 10,000 52.48 524,800
2019-04-26 FLIR Sale 23,116 51.33 1,186,544
2019-03-01 FLIR Sale 100,000 51.37 5,137,000
2019-03-01 FLIR Option Ex 100,000 30.27 3,027,000
2019-02-26 FLIR Sale 132,100 52.11 6,883,731
2019-02-26 FLIR Option Ex 132,100 30.27 3,998,667
2018-08-30 FLIR Sale 20,000 62.25 1,245,000
2018-08-17 FLIR Sale 15,000 59.99 899,850
2018-08-16 FLIR Sale 10,000 60.25 602,500
2018-07-27 FLIR Option Ex 189,800 25.64 4,866,472
2018-07-27 FLIR Sale 39,508 59.05 2,332,947
2017-10-27 FLIR Option Ex 129,500 34.31 4,443,145
2017-10-27 FLIR Sale 136,631 47.32 6,465,378
2017-08-16 FLIR Sale 20,000 38.22 764,400
2017-07-31 FLIR Sale 11,587 37.27 431,847
2017-05-12 FLIR Sale 15,000 37.26 558,900
2017-03-20 FLIR Option Ex 250,000 20.75 5,187,500
2016-11-03 FLIR Sale 52,000 32.40 1,684,800
2016-06-03 FLIR Sale 52,288 30.99 1,620,405
2016-03-10 FLIR Sale 11,625 31.10 361,537
2016-03-03 FLIR Sale 9,050 31.95 289,147
2016-02-19 FLIR Sale 30,000 30.61 918,300
2015-12-03 FLIR Sale 50,000 30.13 1,506,500
2015-07-28 FLIR Sale 49,992 29.95 1,497,260
2015-05-27 FLIR Sale 35,000 30.86 1,080,100
2015-05-05 FLIR Option Ex 146,538 12.57 1,841,982
2015-05-04 FLIR Option Ex 20,000 12.57 251,400
2015-05-04 FLIR Sale 20,000 31.48 629,600
2015-05-05 FLIR Sale 59,538 31.47 1,873,660
2015-05-01 FLIR Option Ex 30,000 12.57 377,100
2015-04-30 FLIR Option Ex 30,000 12.57 377,100
2015-04-30 FLIR Sale 30,000 30.72 921,600
2015-05-01 FLIR Sale 30,000 31.07 932,100
2015-04-29 FLIR Option Ex 20,000 12.57 251,400
2015-04-28 FLIR Option Ex 20,000 12.57 251,400
2015-04-28 FLIR Sale 20,000 30.91 618,200
2015-03-06 FLIR Sale 5,714 31.59 180,505
2015-02-17 FLIR Sale 15,218 32.59 495,954
2015-02-11 FLIR Option Ex 7,954 12.57 99,981
2015-02-11 FLIR Sale 9,068 32.76 297,067

Table 4. Insider trading of Nxstage Medical, Inc. (NXTM) by Lewis Earl

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-11-02 NXTM Option Ex 33,468 14.29 478,425
2016-05-25 NXTM Option Ex 14,000 18.55 259,700
2015-11-18 NXTM Sale 18,020 19.76 356,075
2016-02-12 NXTM Buy 21,000 14.48 304,017
2015-02-20 NXTM Option Ex 14,000 13.88 194,320

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lewis Earl (Director of Tecogen Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.